GlassScriptPhysician profile
David M Cumes
NPI 1366523938
$1,471.33
in general payments reported to CMS, 2019-2025
12 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $151 · 2021: $39.83 · 2022: $214 · 2023: $403 · 2024: $106 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $106 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105.53 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $344.28 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $224.46 | 2025 | Rybrevant, Carvykti, Erleada |
| Edap Technomed INC | $185.00 | 2022 | |
| Procept Biorobotics Corporation | $134.99 | 2020 | |
| Biotissue Holdings INC. | $121.62 | 2023 | |
| Pfizer INC. | $113.68 | 2019 | |
| Progenics Pharmaceuticals, INC. | $105.86 | 2023 | Pylarify |
| Sumitomo Pharma America, INC. | $105.53 | 2024 | Gemtesa |
| Laborie Medical Technologies Corp. | $50.95 | 2023 | |
| Myovant Sciences INC. | $39.83 | 2021 | |
| 180 Medical, INC. | $29.46 | 2022 | |
| Coloplast Corp | $15.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cumes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.